Vincent P. Ippolito, EVP & Chief Commercial Officer at Anacor Pharmaceuticals, Inc. (ANAC), sold 14,525 shares at $62.23 ($931K) on 2016-03-02, disclosed to the SEC on 2016-03-04.
Open-market sale of $931k ANAC by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.23 | 1,600 | $100K | 10.7% |
| 2 | $63.56 | 1,875 | $119K | 12.8% |
| 3 | $64.22 | 3,696 | $237K | 25.5% |
| 4 | $64.22 | 3,696 | $237K | 25.5% |
| 5 | $64.88 | 1,829 | $119K | 12.7% |
| 6 | $64.88 | 1,829 |
| $119K |
| 12.7% |
| Total | $64.08 avg | 14,525 | $931K | 100% |
| Filing → |
| ANAC | SELL | 2015-12-11 | $2.2M | — | Filing → |
| ANAC | SELL | 2015-03-04 | $395K | — | Filing → |
| MRX | SELL | 2011-05-17 | $4.2M | — | Filing → |